Latest Episodes
Colorectal and gastric cancer: Current and future therapeutic approaches. Part 2 - Immunotherapy
In this podcast series, Dr. Jenny Seligmann (University of Leeds, UK), Dr. Autumn McRee (University of North Carolina, USA) and Dr. Dominik Modest (Charité...
Colorectal and gastric cancer: Current and future therapeutic approaches. Part 1 - Targeted therapy
In this podcast series, Dr. Jenny Seligmann (University of Leeds, UK), Dr. Autumn McRee (University of North Carolina, USA) and Dr. Dominik Modest (Charité...
Multiple Myeloma: Choosing the best treatment regimen in patients with relapsed/refractory MM - Part 2
In this medical education podcast series, myeloma experts Dr. Karthik Ramasamy (Haematologist and Associate Professor of Haematology at the Oxford University Hospitals in London,...
HCC: VEGFR-TKI monotherapy for unresectable or advanced HCC in 1st line setting
Prof. Josep Llovet and Prof. Stephen L. Chan discuss a very interesting topic about the use of the VEGFR TKIs monotherapy in the treatment...
Multiple Myeloma: Choosing the best treatment regimen in newly diagnosed patients - Part 1
In this medical education podcast series, myeloma experts Dr. Joshua Richter (Assistant Professor of Medicine and Director of Myeloma at the Tisch Cancer Institute...
HCC: Highlights from ILCA and ESMO 2021
Professor Matthias Pinter, medical hepatologist from the medical University of Vienna in Austria shares some insights from key abstracts and topics discussed at ILCA...